Vfend and Ecchymosis - a phase IV clinical study of FDA data

Summary:

Ecchymosis is reported as a side effect among people who take Vfend (voriconazole), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Gaviscon, and have Asthma.

The phase IV clinical study analyzes which people have Ecchymosis when taking Vfend. It is created by eHealthMe based on reports of 12,081 people who have side effects when taking Vfend from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Ecchymosis?

Ecchymosis (a discoloration of the skin resulting from bleeding underneath) is found to be associated with 1,016 drugs and 1,083 conditions by eHealthMe. Check the latest studies of Ecchymosis.

On Aug, 05, 2026

12,081 people reported to have side effects when taking Vfend.
Among them, 13 people (0.11%) have Ecchymosis.

Among these 13 people:

How long have people been on Vfend when they have Ecchymosis? *

What is the gender of people who have Ecchymosis when taking Vfend? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Ecchymosis when taking Vfend? *

What are other drugs people take besides Vfend? *

Bactrim: 6 people, 46.15%
Gaviscon: 6 people, 46.15%
Ventolin: 4 people, 30.77%
Meropenem: 2 people, 15.38%
Deferasirox: 2 people, 15.38%
Dexamethasone: 2 people, 15.38%
Fluticasone Propionate: 2 people, 15.38%
Ibrutinib: 2 people, 15.38%
Lactulose: 2 people, 15.38%
Acetaminophen: 2 people, 15.38%

What are other side effects people have besides Ecchymosis? *

Oedema Peripheral (superficial swelling): 7 people, 53.85%
Pain In Extremity: 7 people, 53.85%
Cryoglobulinaemia (blood contains large amounts of cryoglobulins - proteins): 6 people, 46.15%
Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 4 people, 30.77%
Thrombocytopenia (decrease of platelets in blood): 4 people, 30.77%
Fever: 3 people, 23.08%
Rashes (redness): 3 people, 23.08%
Bleeding Into The Skin: 3 people, 23.08%
Nosebleed (bleeding from nose): 2 people, 15.38%
Prurigo (chronic skin disease causing severe itching): 2 people, 15.38%

What are the existing conditions these people have? *

Asthma: 6 people, 46.15%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 15.38%
Tumor: 1 person, 7.69%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.69%
Canker Sores (painful, open sore in the mouth): 1 person, 7.69%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 7.69%
Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 1 person, 7.69%
Diarrhea: 1 person, 7.69%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 7.69%
Gastric Ulcer (stomach ulcer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and have Ecchymosis?

- Check whether Ecchymosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vfend:

Vfend (12,128 reports)

Ecchymosis treatments and more:

Ecchymosis (13,357 reports)

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ecchymosis:

Ecchymosis (1,016 drugs)

Browse all the conditions that are associated with Ecchymosis:

Ecchymosis (1,083 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole (the active ingredients of Vfend) and Vfend (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.